India Tightens Oversight on GLP-1 Drugs Over Safety and Misuse Risks
New Delhi— India’s drug regulators are increasing scrutiny of a fast-growing class of medicines known as GLP-1 receptor agonists, amid concerns about their safety and potential misuse. These drugs are widely used to manage Type 2 Diabetes and are increasingly … read more









